[October 02, 2014] |
|
Research and Markets: Uveitis Market Analysis 2014-2015 - API Manufacturers and Phase III Pipeline Assessment
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/2rjtrf/uveitis_market)
has announced the addition of the "Uveitis-
Market Analysis, Global API Manufacturers and Phase III Pipeline
Assessment, 2014" report to their offering.
Uveitis- Market Analysis, Global API Manufacturers and Phase III
Pipeline Assessment, 2014 provides comprehensive insights about phase
III pipeline drugs and marketed drugs across the indication. A key
objective of the report is to establish the understanding for API
Manufacturers for marketed and Phase III pipeline drugs across the
different countries and regions. While the leading brands, companies and
chemicals are considered thoroughly, the report also provides details on
the drug master filings across the US, Europe and Asia specifically
China and India.
The research, analysis also presents the global sales forecasts data
till 2015. The report is also giving insight about the patent and
exclusivity details of all the drugs across the indicaion.
Key Topics Covered:
-
Indication Overview
-
Marketed Drugs Assessment
-
Marketed Details of Drugs by Application Type
-
Marketed Details of Drugs (NDA) by Marketing Status
-
Marketed Details of Drugs by Patent Expiration Timeline (News - Alert)
-
The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
-
The API Manufacturers by the United States Drug Master File (US DMF)
Status
-
The API Manufacturers by the US DMF Status (Drug Specific)
-
The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
for Phase III Pipeline Drugs
-
The API Manufacturers by the US DMF Status (Drug Specific)
-
Drugs Market Data and Forecasted Sales Figures (2011-2015)
-
Marketed Drugs Information
-
Drugs Description
-
Route of Synthesis
-
Global Active Pharmaceutical Manufacturers
-
Approval Status
-
Patent and Exclusivity Details
-
Company Overview
-
Phase III Drugs Information
-
Phase III Drugs Description
-
The United States Drug Master Filings (US DMF)
-
Discontinued Drugs Information
Companies Mentioned
-
Allergan, Inc.
-
Alcon, Inc.
-
Horizon Pharma, Inc.
-
Merck & Co., Inc.
-
Bausch & Lomb Incorporated
-
Alcon Laboratories, Inc.
-
Pharmacia & Upjohn, Inc.
-
Pfizer Inc.
-
Roxane Laboratories, Inc.
-
Falcon Pharmaceuticals, Ltd.
-
Organon USA Inc.
-
Apothecon Inc
-
Schering-Plough Corporation (Inactive)
-
Merck Sharp (News - Alert) & Dohme Corp.
-
Sanofi
-
Questcor Pharmaceuticals, Inc.
-
Sandoz Inc.
-
Panray Corporation
-
Novartis AG
-
UCB, Inc.
-
Tiber Laboratories, LLC
-
Concordia Pharmaceuticals Inc.
For more information visit http://www.researchandmarkets.com/research/2rjtrf/uveitis_market
[ Back To TMCnet.com's Homepage ]
|